The Hemodynamic Stability of Dexmedetomidine during Laparoscopic Uterine Fibroids Surgery: A Randomized Controlled Study

Background: The aim of this study was to determine whether dexmedetomidine can reduce the circulatory response in laparoscopic uterine fibroids (UF) surgery. Our purpose was to investigate the effect of dexmedetomidine on the circulatory response in laparoscopic UF surgery. Methods: This was a rando...

Full description

Saved in:
Bibliographic Details
Main Authors: Xia Cao, Xu Ding, Huihui Sun, Lihong Zhang, Xiang Li
Format: Article
Language:English
Published: IMR Press 2024-05-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/51/5/10.31083/j.ceog5105119
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850045731929325568
author Xia Cao
Xu Ding
Huihui Sun
Lihong Zhang
Xiang Li
author_facet Xia Cao
Xu Ding
Huihui Sun
Lihong Zhang
Xiang Li
author_sort Xia Cao
collection DOAJ
description Background: The aim of this study was to determine whether dexmedetomidine can reduce the circulatory response in laparoscopic uterine fibroids (UF) surgery. Our purpose was to investigate the effect of dexmedetomidine on the circulatory response in laparoscopic UF surgery. Methods: This was a randomized controlled study of 214 patients age range of 40–60 years, American Society of Anesthesiologists (ASA) 1–2 grade, undergoing elective laparoscopic UF surgery at Fuxing Hospital, Capital Medical University from January 2020 to October 2023. Patients were randomly allocated to the non-dexmedetomidine group (Group1) and dexmedetomidine group (Group2). The mean arterial pressure (MAP) and heart rate (HR) were measured: when entering the operation room (MAP1, HR1), immediately at the time of local pituitrin injection (MAP2, HR2), and at 5 minutes after injection of pituitrin (MAP3, HR3). The medications and dosages (propofol, urapidil hydrochloride, fluid) used during the operation were recorded as well as the recovery (drowsiness, chills, nausea, vomiting, dysphoria) after the operation. Total mean time from the beginning of the operation to pituitrin injection (Time1) and recovery time after peaking blood pressure with pituitrin injection (Time2) were also recorded. Results: There were no significant differences in age, height, weight, size and number of UFs, and the location of uterine fibroids between the two groups. There were no differences between the groups for MAP1, MAP2, HR1, HR2, HR3, and Time1 (all p > 0.05), but the dexmedetomidine group was smaller in MAP3 (p = 0.041) and Time2 (p = 0.000) than the non-dexmedetomidine group. There were significant differences in MAP3-MAP1 (p = 0.025), propofol (p = 0.011), and urapidil hydrochloride (p = 0.000) between the two groups. The dexmedetomidine group was smaller in chills (p = 0.002), nausea (p = 0.000), vomiting (p = 0.04), and dysphoria (p = 0.024) than the non-dexmedetomidine group. Conclusions: Dexmedetomidine maintains a stable hemodynamic response and is beneficial to postoperative recovery in laparoscopic UF surgery. Clinical Trial Registration: The study has been registered on https://classic.clinicaltrials.gov/ (registration number: NCT03524950).
format Article
id doaj-art-00e9ccf7296649e18209be4b2ec5200e
institution DOAJ
issn 0390-6663
language English
publishDate 2024-05-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj-art-00e9ccf7296649e18209be4b2ec5200e2025-08-20T02:54:37ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632024-05-0151511910.31083/j.ceog5105119S0390-6663(24)02348-0The Hemodynamic Stability of Dexmedetomidine during Laparoscopic Uterine Fibroids Surgery: A Randomized Controlled StudyXia Cao0Xu Ding1Huihui Sun2Lihong Zhang3Xiang Li4Department of Anesthesiology, Fuxing Hospital, Capital Medical University, 100038 Beijing, ChinaDepartment of Anesthesiology, Fuxing Hospital, Capital Medical University, 100038 Beijing, ChinaDepartment of Anesthesiology, Fuxing Hospital, Capital Medical University, 100038 Beijing, ChinaDepartment of Anesthesiology, Fuxing Hospital, Capital Medical University, 100038 Beijing, ChinaDepartment of Anesthesiology, Fuxing Hospital, Capital Medical University, 100038 Beijing, ChinaBackground: The aim of this study was to determine whether dexmedetomidine can reduce the circulatory response in laparoscopic uterine fibroids (UF) surgery. Our purpose was to investigate the effect of dexmedetomidine on the circulatory response in laparoscopic UF surgery. Methods: This was a randomized controlled study of 214 patients age range of 40–60 years, American Society of Anesthesiologists (ASA) 1–2 grade, undergoing elective laparoscopic UF surgery at Fuxing Hospital, Capital Medical University from January 2020 to October 2023. Patients were randomly allocated to the non-dexmedetomidine group (Group1) and dexmedetomidine group (Group2). The mean arterial pressure (MAP) and heart rate (HR) were measured: when entering the operation room (MAP1, HR1), immediately at the time of local pituitrin injection (MAP2, HR2), and at 5 minutes after injection of pituitrin (MAP3, HR3). The medications and dosages (propofol, urapidil hydrochloride, fluid) used during the operation were recorded as well as the recovery (drowsiness, chills, nausea, vomiting, dysphoria) after the operation. Total mean time from the beginning of the operation to pituitrin injection (Time1) and recovery time after peaking blood pressure with pituitrin injection (Time2) were also recorded. Results: There were no significant differences in age, height, weight, size and number of UFs, and the location of uterine fibroids between the two groups. There were no differences between the groups for MAP1, MAP2, HR1, HR2, HR3, and Time1 (all p > 0.05), but the dexmedetomidine group was smaller in MAP3 (p = 0.041) and Time2 (p = 0.000) than the non-dexmedetomidine group. There were significant differences in MAP3-MAP1 (p = 0.025), propofol (p = 0.011), and urapidil hydrochloride (p = 0.000) between the two groups. The dexmedetomidine group was smaller in chills (p = 0.002), nausea (p = 0.000), vomiting (p = 0.04), and dysphoria (p = 0.024) than the non-dexmedetomidine group. Conclusions: Dexmedetomidine maintains a stable hemodynamic response and is beneficial to postoperative recovery in laparoscopic UF surgery. Clinical Trial Registration: The study has been registered on https://classic.clinicaltrials.gov/ (registration number: NCT03524950).https://www.imrpress.com/journal/CEOG/51/5/10.31083/j.ceog5105119dexmedetomidinelaparoscopyleiomyomauterine fibroidsblood circulationhemodynamics
spellingShingle Xia Cao
Xu Ding
Huihui Sun
Lihong Zhang
Xiang Li
The Hemodynamic Stability of Dexmedetomidine during Laparoscopic Uterine Fibroids Surgery: A Randomized Controlled Study
Clinical and Experimental Obstetrics & Gynecology
dexmedetomidine
laparoscopy
leiomyoma
uterine fibroids
blood circulation
hemodynamics
title The Hemodynamic Stability of Dexmedetomidine during Laparoscopic Uterine Fibroids Surgery: A Randomized Controlled Study
title_full The Hemodynamic Stability of Dexmedetomidine during Laparoscopic Uterine Fibroids Surgery: A Randomized Controlled Study
title_fullStr The Hemodynamic Stability of Dexmedetomidine during Laparoscopic Uterine Fibroids Surgery: A Randomized Controlled Study
title_full_unstemmed The Hemodynamic Stability of Dexmedetomidine during Laparoscopic Uterine Fibroids Surgery: A Randomized Controlled Study
title_short The Hemodynamic Stability of Dexmedetomidine during Laparoscopic Uterine Fibroids Surgery: A Randomized Controlled Study
title_sort hemodynamic stability of dexmedetomidine during laparoscopic uterine fibroids surgery a randomized controlled study
topic dexmedetomidine
laparoscopy
leiomyoma
uterine fibroids
blood circulation
hemodynamics
url https://www.imrpress.com/journal/CEOG/51/5/10.31083/j.ceog5105119
work_keys_str_mv AT xiacao thehemodynamicstabilityofdexmedetomidineduringlaparoscopicuterinefibroidssurgeryarandomizedcontrolledstudy
AT xuding thehemodynamicstabilityofdexmedetomidineduringlaparoscopicuterinefibroidssurgeryarandomizedcontrolledstudy
AT huihuisun thehemodynamicstabilityofdexmedetomidineduringlaparoscopicuterinefibroidssurgeryarandomizedcontrolledstudy
AT lihongzhang thehemodynamicstabilityofdexmedetomidineduringlaparoscopicuterinefibroidssurgeryarandomizedcontrolledstudy
AT xiangli thehemodynamicstabilityofdexmedetomidineduringlaparoscopicuterinefibroidssurgeryarandomizedcontrolledstudy
AT xiacao hemodynamicstabilityofdexmedetomidineduringlaparoscopicuterinefibroidssurgeryarandomizedcontrolledstudy
AT xuding hemodynamicstabilityofdexmedetomidineduringlaparoscopicuterinefibroidssurgeryarandomizedcontrolledstudy
AT huihuisun hemodynamicstabilityofdexmedetomidineduringlaparoscopicuterinefibroidssurgeryarandomizedcontrolledstudy
AT lihongzhang hemodynamicstabilityofdexmedetomidineduringlaparoscopicuterinefibroidssurgeryarandomizedcontrolledstudy
AT xiangli hemodynamicstabilityofdexmedetomidineduringlaparoscopicuterinefibroidssurgeryarandomizedcontrolledstudy